PCSK9 association with LDL: Effects of anti-PCSK9 mAbs therapy von Canclini, L., Baragetti, A., Jabnati, N., Malvandi, A.M., Grigore, L., Catapano, A.L.

Volltext

An evaluation of different methods to study the association of proprotein convertase subtilisin-kexin type 9 to lipoproteins von Canclini, L., Malvandi, A.M., Uboldi, P., Zampoleri, V., Baragetti, A., Grigore, L., Catapano, A.L.

Volltext

Proprotein convertase subtilisin/kexin type 9 (PCSK9) association to LDL in patients treated with anti-PCSK9 monoclonal antibodies von Canclini, L., Jabnati, N., Malvandi, A.M., Baragetti, A., Grigore, L., Catapano, A.L.

Volltext

Optimizing the method of plasma lipoprotein isolation for elucidating their differential association to proprotein convertase subtilisin/kexin 9 (PCSK9) von Canclini, L., Malvandi, A.M., Uboldi, P., Zampoleri, V., Bellosta, S., Baragetti, A., Grigore, L., Zambon, A., Catapano, A.L.

Volltext